Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Amplia Therapuetics Limited

News headline image
Amplia Therapeutics Launches First Stage of Registration-Enabling Trial of Narmafotinib
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Accent Trial Mature Data Presented at International Conference
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Poster Presentation Demonstrating Combination Benefit of Narmafotinib in Preclinical Kras-Mutated Cancer Models
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
NARMAFOTINIB Large-Scale Manufactre Complete
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Therapeutics to Present at 2026 ASCO Gastrointestinal Cancers Symposium
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Amplia Enters into Second Agreement with Korean Specialist Drug Screening Company Next&Bio to Explore Combination Therapy with FAK Inhibitor and kRAS Inhibitors
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Additional Confirmed Response Reported as Part of Amplia Investor Presentation
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
News headline image
Key Narmafotinib Patent Granted in the U.S.
From Amplia Therapuetics Limited
Via GlobeNewswire
Tickers ASX:ATX INNMF
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.